Mr. Zeeshan Saeed reports

QUANTUM BIOPHARMA LICENSEE UNBUZZD WELLNESS INC. APPOINTS RICHARD BUZBUZIAN AS CEO TO LEAD NATIONWIDE COMMERCIALIZATION OF INNOVATIVE, CLINICALLY VALIDATED HANGOVER REMEDY AND ALCOHOL METABOLISM ACCELERANT

Quantum Biopharma Ltd. licensee Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.) (the company), the company behind unbuzzd, the scientifically proven beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, has appointed Richard Buzbuzian as chief executive officer. This marks a pivotal milestone in the company's commercialization strategy. With the functional beverage market projected to reach $198-billion in 2026 and expected to grow at a 10.79-per-cent CAGR (compound annual growth rate), Mr. Buzbuzian brings the vision and capital markets acumen required to capitalize on this unprecedented market opportunity. His mandate includes executing a nationwide rollout, beginning with strategic market expansion into South Florida and Texas -- two of America's most dynamic consumer markets, as well as listing the company on a stock exchange.

The company also welcomes John Duffy to his new role as product consultant and wishes to thank Mr. Duffy for his contributions to date. Previously, Mr. Duffy was chief executive officer of the company and is now assisting in product development and national distribution in a consultancy role.

Clinically validated, science-backed innovation

unbuzzd stands apart in the wellness and recovery supplement landscape as the only product backed by a peer-reviewed clinical study proving its efficacy in accelerating alcohol metabolism, restoring mental clarity and reducing hangover symptoms. In an era where clinical validation drives investor confidence and consumer trust, unbuzzd's proprietary formulation positions the company as a category-defining leader in the functional beverage space.

The peer-reviewed clinical study, which investigated the effects of unbuzzd on alcohol intoxication and alcohol metabolism, was published in the World Journal of Pharmaceutical and Medical Research (2026, Volume 12, Issue 3, pages 446 to 467).

Addressing health-conscious consumer demand

The shift toward better-for-you beverages continues to accelerate, with 70 per cent of Americans actively seeking health benefits from their beverage choices and 72 per cent of Gen Z consumers trying new beverages monthly. unbuzzd addresses this consumer demand through a clean-label approach -- a proprietary blend of vitamins, minerals and herbs developed by a world-class R&D (research and development) team in pharmacology and medicine. Unlike competitors targeting only hydration or hangover symptoms, unbuzzd combines both with metabolic science in convenient ready-to-mix powder stick formats.

Scalable platform for multichannel distribution

The company's growth strategy targets an expansive retail footprint including pharmacies, liquor stores, supermarkets, mass merchandisers, convenience stores and college stores -- a multichannel distribution approach mirroring successful nationwide rollouts by industry leaders. With national distribution capabilities and a scalable platform for both retail and e-commerce, unbuzzd is positioned to capture significant share of the total addressable market for alcohol recovery and functional wellness beverages across North America and international markets.

"As unbuzzd begins commercialization, we are pleased to announce Richard's appointment as the company sets its first geographic regions for sales," commented Dr. Eric Hoskins, director. "Buzbuzian's vision, business acumen and understanding of capital markets comes to unbuzzd as we pursue market expansion across North America and abroad in retail and on-line settings. With the functional beverage market on track to exceed $198-billion and consumer demand for clinically validated, better-for-you products at an all-time high, the timing could not be more opportune."

"The total addressable market for unbuzzd is substantial, creating an exciting commercial opportunity that begins with our nationwide rollout in the United States," commented Mr. Buzbuzian, CEO. "Many products exist that target either hydration or hangover symptoms, but none combine the two with proven metabolic science backed by a peer-reviewed study. This category-defining positioning, combined with our clean-label formulation, delivers exactly what today's health-conscious consumers demand. An incredible commercial opportunity exists in this $198-billion market, and we are positioned to capitalize on it with our scalable platform and strategic retail partnerships.

"Innovation remains central to our long-term growth strategy," added Mr. Buzbuzian. "We are building a sustainable, scalable platform capable of delivering ready-to-drink formats and expanding our proprietary product line to meet evolving consumer demand for functional, better-for-you beverages."

About Quantum Biopharma Ltd.

Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., Quantum Biopharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum Biopharma invented unbuzzd and spun out its OTC (over-the-counter) version to a company, Unbuzzd Wellness Inc. (UWI), led by industry veterans. Quantum Biopharma retains ownership of 19.84 per cent (as of Dec. 31, 2025) of UWI. The agreement with UWI also includes royalty payments of 7 per cent of sales from unbuzzd until payments to Quantum Biopharma total $250-million. Once $250-million is reached, the royalty drops to 3 per cent in perpetuity. Quantum Biopharma retains 100 per cent of the rights to develop similar product or alternative formulations specifically for pharmaceutical and medical uses.

About Unbuzzd Wellness Inc.

Unbuzzd Wellness, a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd has been developed by a world-class R&D team in pharmacology and medicine, with a commitment to innovation and quality. A proprietary blend of vitamins, minerals and herbs, unbuzzd helps your body process alcohol faster, restore mental alertness and improve cognition so you can drink responsibly and feel great the next day. unbuzzd ready-to-mix powder sticks are available in three-pack, eight-pack and 18-pack formats on-line.

We seek Safe Harbor.